News Conference News NY Valves 2025 Prompt TAVI Benefits Asymptomatic AS Patients Regardless of Guideline Indication Todd Neale June 27, 2025
News Daily News Cardiac Biomarkers May Help Refine HF Risk Stratification, Progression L.A. McKeown February 17, 2023
News Conference News AHA 2022 Drug Preconditioning Before CABG, Valve Surgery Shows Promise: START Todd Neale November 14, 2022
News Daily News Concerning or Reassuring? Long After COVID-19, CMR Still Yields Clues Michael O'Riordan October 03, 2022
News Conference News ESC 2022 CV Care Around Noncardiac Surgery: New ESC Guidelines Michael O'Riordan September 07, 2022
News Conference News EuroPCR 2022 Changes in Cardiac Damage After AVR Tied to 2-Year Outcomes Caitlin E. Cox May 17, 2022
News Daily News VISION Eyeballs Too-Low Troponin Values for MI, Injury After Cardiac Surgery L.A. McKeown March 04, 2022
News Daily News Cardiac Abnormalities Seen After COVID-19, but Recovery Is Quick Michael O'Riordan January 20, 2022
News Daily News New US Valve Guidance Tackles TAVR vs TAVI, Low-risk AS, Functional MR Caitlin E. Cox December 23, 2020
Presentation TCT 2020 TCT 147: Limitations of Established Cardiac Biomarkers in Low- to Intermediate-Risk TF-TAVR Patients With Advanced CKD Presenter: Hatim Seoudy October 14, 2020
News Daily News LV Mass Regression After TAVR Linked to Better Long-term Outcomes Michael O'Riordan May 13, 2020
News Conference News AHA 2019 Early Surgery Beats a Conservative Approach in Asymptomatic AS: RECOVERY Yael L. Maxwell November 16, 2019
Presentation TCT Abstracts Posters 2019 Combination of Preoperative Frailty Status and Cardiac Biomarkers for Improving Risk Stratification in TAVR Presenter: Francisco Romeo October 02, 2019
News Daily News Echo Parameters Identify At-Risk Asymptomatic Patients With Severe AS Michael O'Riordan October 03, 2018
News Daily News Hemodynamic Deterioration Post-SAVR: Dysmetabolic Profile, Calcification Could Be Early Warning Signs Caitlin E. Cox July 10, 2018
News Industry News MyoKardia Provides Update on Two Phase 1 Trials of MYK-461 for the Treatment of Hypertrophic Cardiomyopathy October 07, 2015
News Conference News EuroPCR 2012 TAVR Studies Tease Out Influences on Clinical Outcome Caitlin E. Cox May 18, 2012